Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

pfizer europe ma eeig  - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

laboratoire innotech international - pirantelis - geriamoji suspensija - 125 mg/2,5 ml; 125 mg; 250 mg - pyrantel

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

laboratoire innotech international - benzalkonio chloridas - makšties minkštosios kapsulės - 54 mg/4,5 g; 12 mg/g; 60 mg; 20 mg; 18,9 mg - intravaginal contraceptives

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

laboratoire innotech international - neomicino sulfatas/polimiksino b sulfatas/nistatinas - makšties minkštosios kapsulės - 35000 tv/35000 tv/100000 tv - nystatin, combinations

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

laboratoire innotech international s.a.s. - karbocisteinas - sirupas - 50 mg/ml; 20 mg/ml - carbocisteine

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

laboratoire innotech international s.a.s. - ešolcijų (eschscholzia californica) žolės sausasis ekstraktas (2,5:1)/gudobelių (crataegus monogyna/laevigata/oxyacantha) lapų ir žiedų sausasis ekstraktas (2,8-3,8:1)/magnis - plėvele dengtos tabletės - 20 mg/75 mg/75 mg

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

nordic group b.v. - tegafur, gimeracil, oteracil - skrandžio navikai - antinavikiniai vaistai - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

eli lilly nederland b.v. - tirzepatide - cukrinis diabetas, 2 tipas - narkotikai, vartojami diabetu - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 ir 5.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

mylan pharmaceuticals limited - memantino hidrochloridas - alzhaimerio liga - other anti-dementia drugs, psychoanaleptics, - gydymas pacientams, sergantiems vidutinio sunkumo ar sunkia alzhaimerio liga.